Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

Dengue Vaccine Market Analysis, Overview, Drivers and Restraints

Dengue fever, often known as breakbone fever, is a viral virus transmitted by mosquitos that causes a severe flu-like disease. Severe dengue fever is a potentially fatal consequence of the disease. Dengue vaccine is a human vaccine that prevents dengue disease. Dengue fever is an infectious disease spread by mosquitos that affects both animals and humans. It is caused by the dengue virus, which belongs to the Flaviviridae family and genus Flavivirus. It spreads from one person to another through the bite of an infected Aedes Aegypti mosquito. Dengue fever is characterised by a high temperature, exhaustion, headache, diarrhoea, muscle discomfort, skin rashes, anaemia, and vomiting. Seizures, yellow skin, unconsciousness, and even death are among symptoms of dengue fever in its most severe form. It has a high death rate and can lead to significant neurological problems. Dengue fever causes CNS symptoms such as aberrant neurological signals, altered consciousness, delirium, and generalised and localised convulsions.

Global Dengue Vaccine Market: Drivers

Over the forecast period, the worldwide dengue vaccine market is expected to rise due to rising dengue prevalence. According to the Pan American Health Organization, a total of 1,191,815 cases of dengue fever were recorded in the Americas region between epidemiological weeks 1 and 22 of 2019, with 546,589 cases being laboratory-confirmed and 5,599 being categorised as severe dengue.

Dengue Vaccines Market
Dengue Vaccine Market


Furthermore, market expansion is likely to be aided by R&D of live attenuated vaccines. Dengvaxia, for example, was licenced by the US Food and Drug Administration in May 2019 for the prevention of dengue fever caused by all dengue virus serotypes. It's a chimaera vaccine developed with recombinant DNA that's live attenuated and tetravalent.

Global Dengue Vaccine Market: Restraints

The market's growth is projected to be hampered by the inability to distinguish dengue fever from other febrile disorders. The symptoms of mosquito-borne infections like Zika, chikungunya virus infection, and dengue fever, for example, are extremely similar, making diagnosis challenging. Furthermore, the market's expansion is projected to be hampered by a lack of understanding of the pathophysiology of dengue infection and a lack of appropriate animal models.

Comments

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Survival Suits Market Size, Share, Outlook, and Opportunity Analysis, 2023-2030

Global Ophthalmoscopes Market Overview and Impact of Coronavirus (Covid-19) Pandemic